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Abstract
Background: Multipotent stem cells have been successfully isolated from various tissues and are currently utilized
for tissue-engineering and cell-based therapies. Among the many sources, skin has recently emerged as an
attractive source for multipotent cells because of its abundance. Recent literature showed that skin stromal cells
(SSCs) possess mesoderm lineage differentiation potential; however, the endothelial differentiation and angiogenic
potential of SSC remains elusive. In our study, SSCs were isolated from human neonatal foreskin (hNFSSCs) and
adult dermal skin (hADSSCs) using explants cultures and were compared with bone marrow (hMSC-TERT) and
adipose tissue-derived mesenchymal stem cells (hADMSCs) for their potential differentiation into osteoblasts,
adipocytes, and endothelial cells.
Results: Concordant with previous studies, both MSCs and SSCs showed similar morphology, surface protein
expression, and were able to differentiate into osteoblasts and adipocytes. Using an endothelial induction culture
system combined with an in vitro matrigel angiogenesis assay, hNFSSCs and hADSSCs exhibited the highest tube-
forming capability, which was similar to those formed by human umbilical vein endothelial cells (HUVEC), with
hNFSSCs forming the most tightly packed, longest, and largest diameter tubules among the three cell types.
CD146 was highly expressed on hNFSSCs and HUVEC followed by hADSSCs, and hMSC-TERT, while its expression
was almost absent on hADMSCs. Similarly, higher vascular density (based on the expression of CD31, CD34, vWF,
CD146 and SMA) was observed in neonatal skin, followed by adult dermal skin and adipose tissue. Thus, our
preliminary data indicated a plausible relationship between vascular densities, and the expression of CD146 on
multipotent cells derived from those tissues.
Conclusions: Our data is the first to demonstrate that human dermal skin stromal cells can be differentiated into
endothelial lineage. Hence, SSCs represents a novel source of stem/stromal cells for tissue regeneration and the
vascularization of engineered tissues. Moreover, the CD146 investigations suggested that the microenvironmental
niche might contribute to direct stromal cells multipotency toward certain lineages, which warrants further
investigation.
Background
There is growing need for novel technologies to restore,
maintain, and enhance organ function. Since the 90s,
stem cells have emerged as a new venue for regenerative
medicine and tissue engineering. Human embryonic
stem (ES) cells, induced pluripotent stem (iPS) cells and
mesenchymal stem cells (MSCs), all has emerged as
potential source for regenerative medicine and tissue
engineering applications [1]. Among those, MSCs appear
to have several advantages including the possibility of
using autologous cells and the excellent safety record
when transplanted into humans [2]. Currently, there is
urgent need for engineered blood vessels to treat sub-
jects with peripheral and coronary artery disease and for
the vascularization of engineered tissues [3]. In general,
MSCs have been isolated and characterized from
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sue [4], umbilical cord blood [4], placenta [5], umbilical
cord matrix [6], amniotic membrane [6] and dental pulp
[7], and also been found in the stroma of various tissues
and organs. Previous studies proved MSCs endothelial
lineage differentiation and vascular potential [7-11]. Vas-
culogenesis and angiogenesis are the two major pro-
cesses responsible for the development of blood vessels
(i.e., neovascularization). The formation of endothelial
tissue (vasculogenesis) is a course of action, referred to
as the in situ formation of blood vessels from EPCs
(endothelial progenitor cells) or angioblasts. These are
differentiated from mesodermal cells and are prear-
ranged to form a capillary network structure by growth
and fusion of multiple blood islands [12,13]. Alterna-
tively, angiogenesis will also result in new blood vessels
arbitrated through the sprouting of new capillaries from
pre-existing vessels, which happens in situations such as
embryonic development [14,15].
Therapeutic angiogenesis is an essential process to
maintain the integrity and treat disorders of insufficient
perfusion of tissue by modulating the endothelial func-
tion or promoting blood vessels growth and prolifera-
tion. MSC-mediated vascular regeneration has been
studied in vitro and in vivo, using angiogenic cytokines
and growth factor supplements such as vascular
endothelial growth factor (VEGF), basic fibroblast
growth factor (bFGF) and hepatocyte growth factor
(HGF) in attempt to enhance vasculogenesis when endo-
genous neovascularization is inadequate [16].
Several preclinical and clinical trials have demon-
strated positive outcomes with MSCs in limb ischemia,
ischemic stroke and peripheral ischemia with systemic
sclerosis, spinal cord injury, and acute myocardial
infarction [17-24]. In most of these cases, MSCs gener-
ated vascular network, reduced skin necrosis and
restored the blood flow [17-24]. In another study, MSCs
alone or co-cultured with EC promoted wound healing
in diabetic and non diabetic animal models through the
differentiation process and secretion of proangiogenic
factors [25-30]. Hence, these investigations were indica-
tive that, MSCs have paracrine effects through the secre-
tion of a number of bioactive factors such as cytokines
and growth factors that rejuvenate the injured or dis-
eased tissues. Recently, MSC like population has been
identified in skin dermis with immunoregulatory proper-
ties, multipotent differentiation into adipocyte, osteo-
blast, chondrocyte, neuron, hepatocyte and insulin-
producing pancreatic cells (Table 1) [31-38]. These
results suggest that, under the defined microenviron-
ment, it is achievable to tailor the differentiation of
MSC-like stromal cells into numerous types of cells for
therapeutic applications. The angiogenic property of
skin derived cells has been showed indirectly by
previous studies, when co-cultured with EC. EC formed
capillary-like tubes in response to paracrine factors
secreted by skin cells, especially VEGF [39-41]. Further-
more, another study showed that the neosynthesis of
extracellular matrix by skin cells is an important factor
in in vitro angiogenesis [42]. Herein we report for the
f i r s tt i m et h a tS S C sh a v et h epotential to differentiate
into endothelial-like cells and to form capillary network
using an in vitro Matrigel (MG) angiogenesis assay.
Using qRT-PCR and immunofluorescent imaging, differ-
entiated cells expressed several markers (vWF, VEGFR,
etc.) supporting their endothelial commitment. Our
findings have significant implications for the utilization
of SSCs as a novel source of multipotent cells for tissue
engineering and regeneration.
Results
Morphology and characterization of cultured cells
The adherent cultured human MSC-TERT, ADMSCs,
ADSSCs and NFSSCs exhibited fibroblast-like, spindle-
shaped morphology when observed under light micro-
scope (Figure 1a). Nonetheless, all groups were positive (>
90%) for stromal cell-associated markers (CD105, CD90,
CD73, CD29, CD13, and CD44), and were negative (< 1%)
for endothelial and hematopoietic lineage markers (CD45,
CD34, CD31, CD14, and HLA DR) (Figure 1b), indicating
great similarities between MSCs and SSCs. HUVEC
expressed high levels (> 90%) of CD105, CD73, CD29,
CD13, CD44 and CD31, and were dim positive for CD34
(> 7%) and HLADR (> 20%), and were negative for CD90,
CD45 and CD14 (Figure 1b). The endothelial differentia-
tion experiments were conducted on hADMSCs,
hADSSCs and hNFSSCs at passage 4; while the immorta-
lized hMSC-TERT cells were acquired at passage 47.
Adipogenic and osteogenic differentiation potential
We assessed the differentiation potential of cultured
MSCs and SSCs. When induced in adipogenic medium
for 15 days, hMSC-TERT, hADMSC, hADSSCs, and
hNFSSCs began to accumulate intracellular lipid
vacuoles that progressively filled the cytoplasm adjacent
to the cell membrane, and were positive for Oil Red O
staining, confirming their adipogenic phenotype (Figure
2a). Similarly, cells induced under osteogenic conditions
exhibited positive alkaline phosphatase (ALP) staining,
thus confirming their osteogenic differentiation. By con-
trast, non-induced control cells didn’t reveal any positive
staining. Notably, hADSSCs and hNFSSCs cells demon-
strated less osteogenic and adipogenic differentiation
potential when compared to MSCs (Figure 2a and 2b).
Differentiation of MSCs and SSCs into Endothelial Cells (EC)
In order to assess the endothelial differentiation poten-
tial of hMSC-TERT, hADMSCs, hADSSCs and
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Page 2 of 13Table 1 Multipotency of skin derived fibroblasts showed by previous studies
Name Origins Dissociation Cultivation
methods
Morphology Expression of
markers
Species Multipotency (in
vitro)
References
Dermis-
derived
multipotent
stem cells
(DMCs)
Newborn
dermis
Enzymatic
digestion
IMDM with 10 ml/
L FBS and 100 U/
mL penicillin and
100 microgram/
mL streptomycin.
Adherent
cells -
spindle
shaped
DMCs were positive
for CD59, CD90, CD44,
vascular cell adhesion
molecule-1 (VCAM-1)
and intercellular
adhesion molecule-1
(ICAM-1). DMCs were
negative for pan-
cytokeratin,
cytokeratin19, factor
VIII, CD31, CD45, CD34,
a-smooth muscle actin
(a-SMA), desmin,
collagen II and nestin.
DNA microarray -
G8Genes associated
with pancreatic cells,
transcripts for
epithelial cell, neural
cell, and hepatocyte as
well.
Animal Adipocyte,
Osteoblast,
Chondrocyte, Neuron
and insulin-
producing pancreatic
cell.
Chun-
Meng Shi
et al (2004)
[34]
Skin derived
pre cursors
(SKPs)
Neonatal
mice
Trypsin and
collagenase
S-MEM with 8%
FBS treated with
Chelex resin. 3D -
culture done.
Adherent
cells -
spindle
shaped
CD49f, CD49, CD117,
CD34 were positive
CD45 negative.
Animal Adipocyte,
chondrocyte,
osteoblast and
muscle
Crigler L et
al (2007)
[37]
MSC like
scalp-derived
adherent cells
(hSCPs)
Scalp
tissues
0.1% trypsin DMEM-HG, 20%
FBS with 20 ng/
ml epidermal
growth factor
(EGF) and 20 ng/
ml FGF2
Adherent
cells -
spindle
shaped
CD44, CD49 (d, e, f),
CD166, CD105, CD29,
SH2, SH4, CDw90,
EGFR, PDGFRa
Human Adipocyte,
Osteoblast,
Chondrocyte and
Neuron
Daniel Tzu-
bi Shih et
al (2005)
[32]
Human
Fibroblasts
equivalent to
MSCs
Apical
skin
collagenase
(1-2 mg/ml)
RPMI 1640 with
20% FCS,
glutamine,
penicillin and
streptomycin
Adherent
cells -
spindle
shaped
CD73, CD90, CD105,
MHC class I and
CD271 are positive.
CD31, CD34, CD45,
HLA DR, CD19, CD14
are negative
Human Multipotency study
not done but
demonstrated
fibroblasts are
Immunoregulatory
Cells and Functionally
Equivalent to MSCs.
Muzlifah A.
Haniffa et
al (2007)
[31].
Multipotenet
fibroblasts
Foreskin Collagenase DMEM containing
10% FBS.
Adherent
cells -
spindle
shaped
CD13 (62.1%), CD29
(53.2%), CD49d
(38.4%), CD105 (30.9%),
Stro-1 (8%) and a low
level of CD34 (1.7%),
negative for CD45,
CD106 and CD133.
Nestin negative,
Vimentin positive.
Human Adipocyte,
Osteoblast,
Chondrocyte, Neuron
and Hepatocyte (6.4%
population are
tripotent),19.1% of
clones were bipotent
and 10,6% of the
clones were
unipotent.
Fu Guo
Chen et al
(2007) [33]
Fibroblastic
mesenchymal
stem-cell-like
cells
Juvenile
foreskin
0.075%
collagenase
DMEM with
GlutaMAX-I, 4.5 g ⁄
l glucose and
pyruvate and 10%
FBS.
Adherent
cells -
spindle
shaped
CD14(-), CD29(+),
CD31(-), CD34(-), CD44
(+), CD45(-), CD71(+),
CD73 ⁄ SH3-SH4(+),
CD90 ⁄ Thy-1(+),
CD105 ⁄ SH2(+), CD133
(-) and CD166 ⁄ ALCAM
(+). Expressed
vimentin, fibronectin
and collagen; they
were less positive for
a-smooth muscle actin
and nestin, while they
were negative for
epithelial cytokeratins.
Human Adipocyte and
chondrocyte
Katrin
Lorenz et
al (2008)
[36]
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Page 3 of 13hNFSSCs, cells were induced for 7 days as described in
materials and methods. As shown in Figure 3, cell mor-
phology of induced cultures (without MG) did not show
significant difference when compared to non-induced
(without MG) culture conditions, all maintaining fibro-
blast-like spindle shaped morphology. Nonetheless,
induced cultures exhibited similar expression pattern of
stromal lineage CD markers to those seen under non-
induced conditions (Additional file 1: Figure S1 and Fig-
ure 1). The angiogenic capability of induced cells was
then assessed using an in vitro endothelial tube forma-
tion assay, whereas HUVEC cells were used as positive
control. Induced cells were cultured in the presence of
endothelial differentiation cocktail for 7 days, followed
Table 1 Multipotency of skin derived fibroblasts showed by previous studies (Continued)
Dermal
mesenchymal
stem cells
Foreskin Enzymatic
digestion
clonal
subcultivation in
DMEM with
meracaptoethanol
Adherent
cells -
spindle
shaped
CD90 and CD105 were
positive, CD34, c-kit
and CD133 were
negative
Human Adipocyte, osteoblast
and muscle
Bartsch G
et al (2008)
[38]
Multipotent
dermal
fibroblasts
Foreskin Collagenase DMEM-HG with
10% FBS, 300 μg/
m1 L-glutamine,
50 μg/ml vitamin
C, 100 U/ml
penicillin and 100
μg/ml
streptomycin.
Adherent
cells -
spindle
shaped
_ Human Adipocyte, neuron,
hapatocyte and
insulin-producing
islet cells.
Dan Bi et
al (2010)
[35]
Figure 1 Morphologic and phenotypic comparison of different cell types. (a) The human bone marrow immortalized (hMSC-TERT line),
adipose tissue (hADMSCs), and stromal cells derived from adult dermal (hADSSCs) and neonatal foreskin (hNFSSCs) cells were plastic adherent
with a fibroblast-like spindle-shaped morphology (shown at magnification of 10X). (b) Flow cytometry analysis of cell surface protein expression
of stromal cells, endothelial and hematopoietic lineage associated markers. Filled histograms represent cells stained by the corresponding isotype
control antibody. Five thousand events were acquired for analysis.
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Page 4 of 13by migration to matrigel-coated plates. Twenty four
hours later, cells exhibited tube-like interconnected
structures, whereas the percentage of capillaries gradu-
ally increased until discrete matrigel regions were
enclosed by cell islets or tubes (Figure 3, right), which
was similar to capillary structures formed by HUVEC
(Figure 3, bottom left). In contrast, non-induced cells on
matrigel showed scattered populations with very few
tube-like clusters, mainly in the hNFSSCs and hADSSCs
(Figure 3). Notably, hNFSSCs exhibited the highest tube
formation capabilities compared to the other cell types
when cultured on matrigel (Figure 3). To confirm the
endothelial differentiation under our culture conditions,
induced cells on matrigel were stained for CD31, VE-
cadherin, eNOS, VEGF165 and vWF and were visualized
under fluorescent microscope. Non-induced cells did
not express any of these markers, even when cultured
on matrigel (data not shown). On the other hand, cells
induced for 7 days and cultured on matrigel exhibited
significant expression of the aforementioned endothelial
markers (Figure 4). Concordant with the capillary for-
mation data from Figure 3, hNFSSCs and hADSSCs
exhibited the highest expression level of endothelial-
associated markers (Figure 4). To further confirm their
endothelial differentiation, the expression levels of var-
ious endothelial and angiogenesis-associated genes
(Vascular endothelial growth factor receptor 2
(VEGFR2; KDR/flk1), Vascular endothelial cadherin
(VE-Cadherin; CD144), Factor VIII (FVIII; AHF) and
Vascular cell adhesion molecule 1 (VCAM1; CD106))
was assessed in non-induced, induced, and induced plus
matrigel cultured cells using quantitative real-time PCR.
The data presented in Figure 5 demonstrated significant
increases in the expression of VEGFR2, VE-cadherin,
FVIII, and VCAM1 under induction culture conditions,
further supporting their endothelial commitment.
Correlation between vascular density, CD146 expression
and endothelial differentiation
Interestingly, immunohistological examination (CD31,
CD34, Factor VIII, CD146 and smooth muscle actin
(SMA) [11,43]) of adipose, adult dermal skin, and neo-
natal foreskin tissues revealed a higher vascular density
in human neonatal foreskin, followed by dermal skin
and adipose tissue (Figure 6a), which apparently paral-
leled the endothelial differentiation potential of cells
derived from those tissues, suggesting that hNFSSCs
a n dh A D S S C sm i g h tb e“more committed” toward
endothelial differentiation. When we examined CD146
expression by FACS, surprisingly it was predominantly
present on hNFSSCs (> 89%) and hADSSCs (> 78%),
which was close to its expression o HUVEC (100%),
Figure 2 (a) Multilineage differentiation potential of hMSC-TERT, hADMSCs, hADSSCs and hNFSSCs. Cells were induced for 15 days under
osteogenic conditions then were assessed for alkaline phosphatase activity (ALP) to measure osteogenesis, while cells induced for 15 days under
adipogenic conditions were assessed by the development of neutral lipid vacuoles stainable with Oil Red O (shown at magnification of 10×). (b)
Quantitative real-time PCR (qRT-PCR) analysis of adipocyte and osteoblast-associated gene expression in induced cells. After differentiation for1 5
days, cells were harvested, and total RNA was extracted and the expression of adipocyte and osteoblast-associated genes were quantified. Gene
expression was normalized to beta-actin and is presented as fold change compared to control (non-induced cells). Data are shown as mean ± S.
D of at least two independent experiments, n = 5 (except hMSC-TERT cell line).
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TERT (> 20%) and hADMSCs (< 1%) (Figure 6b and
6c). Similarly, immunohistochemical staining of CD146
revealed the same expression trend when comparing
adipose, adult dermal and neonatal foreskin tissues
(compare Figure 6a and 6b).
Discussion
In tissue engineering, development of blood vessel is
one of the most attractive areas of research for the
treatment of vascular diseases and tissue vascularization
[43,44]. Due to the differentiation and proliferation cap-
abilities of MSCs, this cell population is currently an
integral part of regenerative medicine [4,45,46]. ECs are
the main element of a primitive vascular plexus, how-
ever, the communication between ECs and other cells
such as pericytes is also essential for vasculogenesis.
VEGF act as a potential regulator of EC-pericyte interac-
tion and vascular progenitor cell differentiation in early
embryogenesis. Although embryonic stem cells have
been successfully differentiated into endothelial cells in
vitro [47], the use of ES for regenerative medicine is still
controversial. On the other hand, adult blood vessel-
derived ECs have recently been identified for their cap-
ability to form three dimensional vessel-like structures
through in vitro EC co-culture system [48]. Their inade-
quate in vitro proliferation had limited the wide utiliza-
tion of ECs in tissue engineering [49]. Considering
procurement risk and their short lifespan, researchers
have been searching for alternative sources of multipo-
tent stem cells capable of differentiation into endothelial
lineage [50-53]. Thereafter, EC-like cells differentiated
from UCB (umbilical cord blood), placenta, umbilical
cord Wharton’s jelly and adipose tissue derived MSCs
have been reported [8-11]. Recently, it was shown that
skin derived cells have adipogenic and osteogenic differ-
entiation potential [54]. Nonetheless, a number of other
studies revealed that dermal skin cells are multipotent
Figure 3 In vitro angiogenic potential of MSCs and SSCs. Phase contrast image analysis of induced and non-induced hMSC-TERT, hADMSCs,
hADSSCs, hNFSSCs and HUVEC on semisolid medium (Matrigel; MG) in the presence and absence of endothelial growth supplements.
Morphological changes were observed at different time points (0, 24 and 72 h) post culture on matrigel. Images are shown at magnification of
10×. Data are representative of at least two independent experiments.
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Page 6 of 13and are capable of differentiation into neurons, hepato-
cytes, and insulin-producing pancreatic-like cells [33,34].
Consistent with previous studies, herein we demon-
strated that both adult and neonatal stromal cells iso-
lated from adult dermal skin and neonatal foreskin have
similar phenotype to BM and adipose-derived MSCs
and could be differentiated into adipogenic and osteo-
genic lineages under the proper induction conditions
[33,34,37].
More importantly, our current study demonstrated for
the first time that human adult dermal and neonatal
foreskin derived CD13
+ CD29
+ CD44
+ CD73
+ CD90
+
CD105
+ stromal cells are capable of differentiating into
endothelial cells and forming CD31
+ VEGF
+ VE-cad-
herin
+ eNOS
+ vWF
+ capillary tube-like structures.
Abdallah et al. previously reported that hMSC-TERT
cells can undergo endothelial differentiation as evident
by the upregulation of VEGFA, EPAS-1, HIF-2a
(hypoxia-inducible transcriptional factor-2), ETB
(endothelin receptor type B), while no change in VEGFR
gene expression was observed after 3 and 7 days of
induction [55]. When cultured on matrigel, induced
hMSC-TERT stained positive for vWF, which collec-
tively would be consistent with the results obtained in
the current study. Our histological data revealed that
hNFSSCs and hADSSCs are derived from a vascular rich
anatomical regions, compared to hADMSCs (Figure 6a),
suggesting that the differentiation potency might depend
on the tissue from which the cells were derived. When
compared to hMSC-TERT and hADMSCs, hNFSSCs
and hADSSCs demonstrated the highest formation of
tightly-packed capillary tube-like networks in an in vitro
angiogenesis assay. Interestingly and in contrast,
hNFSSCs and hADSSCs showed the least osteogenic
and adipogenic differentiation potential compared to
hMSC-TERT and hADMSCs (Figure 2a and 2b), again
suggesting that the majority of skin-derived stromal cells
might already be committed toward endothelial differen-
tiation to better serve their anatomical location, espe-
cially in the event of wound healing which requires
rapid neovascularization. Concerning basal MSC charac-
terization, all cells isolated from these four sites exhib-
ited typical MSC characteristics: a fibroblastoid
morphology, expression of a typical set of surface mar-
kers (CD13
+ CD29
+ CD44
+ CD73
+ CD90
+ CD105
+), and
lack of the expression of endothelial and hematopoietic
markers (CD34
-,C D 3 1
-,C D 1 4
-,C D 4 5
-,H L A - D R
-).
Therefore, it is unlikely that our culture system
expanded pre-existing endothelial progenitors as the
flow cytometry data clearly demonstrated homogeneous
population of fibroblast-like spindle-shaped cells which
did not express CD34 and CD31 endothelial progenitor
markers [56,57]. Interestingly, our data suggested a pos-
sible correlation between CD146 expression and
Figure 4 Immunofluorescence staining for endothelial-
associated markers 72 h post-induction on matrigel. hMSC-
TERT, hADMSCs, hADSSCs and hNFSSCs were induced for 7 days
and then were plated on matrigel-coated wells. Expression of
endothelial associated markers (CD31, VE-cadherin, eNOS, VEGF165
and vWF) was assesses using immunofluorescence microscopy. 4,6-
Diamidino-2 phenylindole (DAPI) was used to counter stain for cell
nuclei (images are shown at magnification of 10×). Notably,
hNFSSCs exhibited tremendous tightly packed capillary tube-like
structures. Lower right panel is a close-up for vWF staining shown
at 20× magnification.
Figure 5 Quantitative real-time PCR (qRT-PCR) analysis of
endothelial-associated gene expression in induced and non-
induced cells. After endothelial differentiation for 7 days, cells
cultivated on matrigel (MG) and without matrigel (WO MG) for
additional 3 days were harvested, and total RNA was extracted and
the expression of endothelial and angiogenesis-associated genes
were quantified. Gene expression was normalized to beta-actin and
is presented as a fold change over non-induced (control) cells. Data
are shown as mean ± S.D of at least two independent experiments,
n=2 .
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Page 7 of 13Figure 6 Comparative vasculature and CD146 analyses of hMSC-TERT, hADMSCs, hADSSCs, hNFSSCs and HUVEC. (a) Hematoxylin-and
eosin (H&E), Vimentin, CD31, CD34, Factor VIII, CD146 and smooth muscle actin (SMA) staining of human adipose, adult dermal and neonatal
foreskin FFPE tissue sections. Scale Bar = 50 micron. (b) Flow cytometry analysis of CD146 protein surface expression on hMSC-TERT (n = 1),
hADMSCs (n = 6), hADSSCs (n = 6), hNFSSCs (n = 5), HUVEC (n = 1). Filled histograms represent cells stained with the corresponding isotype
control antibody. (c) Quantitative presentation of the percentage of CD146
+ population in different cell types.
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and Figure 3). Consistent with this, recent report has
found that CD146
+ MSCs within bone marrow are loca-
lized in the perivascular region, while the CD146
- cells
were more in the bone lining region, again suggesting a
possible correlation between CD146 expression on
hMSCs and hSSCs and vascular commitment [58]. Cur-
rently, CD146 is regarded one of the commonly
reported positive surface antigens of MSCs, among the
several stem cell associated markers [59]. On the other
hand, CD146 is also considered as an endothelial and
pericyte marker [60]. Therefore, our data suggest that
stromal cell populations that are highly positive for
CD146 might be more inclined to generate endothelial
cells, however this assumption warrants further
investigation.
Conclusions
Our results indicate that SSCs derived from human
adult and neonatal skin, are multipotent that have the
potential to differentiate into endothelial-like cells, in
addition to their adipocytes and osteoblasts differentia-
tion capabilities. Therefore, our data is the first to
demonstrate endothelial-differentiation potential of der-
mal-skin stromal cells, which potentially could have a
myriad of implications toward understanding the basic
biology of wound healing, in tissue engineering, and in
regenerative medicine applications.
Methods
This project was approved by the Institution Review
Board of King Saud University Medical College and
Hospital (10-2815-IRB).
Cell culture
Cells were cultured in Dulbecco’s Modified Eagle Med-
ium (DMEM) supplemented with D-glucose 4500 mg/L,
4 mM L-Glutamine and 110 mg/L Sodium Pyruvate,
10% Fetal Bovine Serum (FBS), 1x penicillin–streptomy-
cin (Pen-strep) and Non essential amino acids (all pur-
chased from Gibco-Invitrogen, USA). hMSC-TERT
(bone marrow immortalized cell line) was kindly
donated by Dr. Mosthafa Kassem, Department of Endo-
crinology and Metabolism, University Hospital of
Odense, Odense, Denmark [61]. Human umbilical vein
endothelial cells (HUVEC) were purchased from Lonza
biotech (CC-2517; Walkersville, USA), it was cultured in
vascular cell basal medium (ATCC; PCS-100-030) sup-
plemented with microvascular endothelial growth factors
(ATCC; PCS-100-041). Adipose tissue and adult dermal
skin were received from patients undergoing abdominal
bariatric surgery, lipectomy, knee replacement or gastro
intestinal operations. Neonatal foreskins were received
from voluntary circumcisions of 2-3 days male babies.
All donors and/or their parents gave written informed
consent for the use of their tissues for scientific pur-
poses. All tissues were washed 3 times with PBS contain
1x Pen-Strep. The epidermis was manually removed
from skin, and the dermis was cut into 1-3 mm pieces,
placed in 3 cm culture dishes where epidermis layer
facing up wards and the dermis layer contacting the cul-
ture surface with few drops of culture medium. Tissues
were incubated at 37°C and 5% CO2 in a humidified
environment. After few hours, and once the tissues were
attached, the level of culture medium was raised and
culture was maintained for a week or until the out-
growth of fibroblast-like spindle shaped cells was visible.
Adipose tissues were minced mechanically then incu-
bated in 1% Collagenase type I (Gibco-Invitrogen, USA)
for 45 min with gentle agitation at 37°C. After inactiva-
tion of collagenase by culture medium DMEM, debris
were separated from pellets of stromal vascular fraction
(SVF) by centrifugation at 500 g for 15 min. SVF cells
were resuspended in culture medium and plated in 25
cm
2 tissue culture flask and maintained in a humidified
incubator at 37°C and 5% CO2. The next day, all non
adherent cells were removed by washing. In few days,
the growth of MSCs was visualized under an inverted
microscope. Cells were fed with fresh medium every 3-4
days until cells reached 70-80% confluency. Residual
skins were removed from explant cultures and adherent
cells were passaged from skin and SVF culture by stan-
dard trypsinization method (Trypsin-EDTA (0.05%);
Gibco-Invitrogen, USA).
Histological examination
The Formalin-Fixed Paraffin-Embedded human adipose
tissue, neonatal and adult skins were stained according
to the manufacturer’s staining protocol on a Bond-
max™ fully automated IHC & ISH staining system
(Leica Microsystems GmbH, Germany) and then stained
with hematoxylin and eosin (H&E) and Vimentin (clone
V9; 1:50), CD31 (clone 1A10; 1:50), CD34 (clone
QBend/10; 1:50), Factor VIII (clone 36B11; 1:100),
CD146 (abcam, USA; clone P1H12; 1:100) and smooth
muscle actin (SMA; clone alpha SM-1; 1:50) using man-
ufacturer’s standard protocols (except CD146 all antibo-
dies from Leica Biosystems Newcastle Ltd; UK). Slides
were digitalized using High-resolution whole-slide digital
ScanScope scanner (Aperio Technologies, Inc.). The
digital slide images were then viewed and analyzed
using the viewing and image analysis tools of Aperio’s
ImageScope software (Aperio Technologies, Vista, CA,
USA).
Endothelial cell differentiation
To assess the endothelial differentiation potential,
hMSC-TERT, ADMSCs, hNFSSCs and hADSSCs were
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2 tissue culture flasks. When cells
reached 70-90% confluency, medium was replaced with
endothelial medium DMEM + 2% FBS, 1% Pen-strep, 50
n g / m LV E G F( R & Ds y s t e m s ,U S A ) ,1 0n g / m Lb F G F
(Sigma-Aldrich, USA) and 50 μg/mL ECGS (endothelial
cell growth supplement, BD Bioscience, USA) for 7
days. Medium was changed every 2 days.
Endothelial cell tube formation (in vitro angiogenesis)
In vitro matrigel angiogenesis assay was utilized to
assess the tube-formation capabilities of hMSC-TERT,
hADMSCs, hADSSCs, and hNFSSCs under normal and
endothelial culture conditions. Matrigel matrix was
thawed on ice at 4°C overnight, then 0.3 ml of chilled
matrigel solution (10 mg/mL, Basement Membrane
Matrix, BD Bioscience) was applied to one well in a 24-
well plate using ice-cooled tips and incubated for 1 h at
37°C. After 7 days of endothelial inductions, both con-
trol and induced cells were trypsinized and platted on
top of the matrigel-coated 24-well plates (2 × 10
4 cells
per well) and were further incubated at 37°C in a 5%
CO2 humidified atmosphere for 1-3 days. Tube forma-
tion assay was carried out along with HUVEC as a posi-
tive control. Tube formation was examined using an
inverted phase-contrast microscope Carl Zeiss–Axio
observer.1 equipped with a digital camera (Axiocam
MRc5).
Immunophenotyping by flow cytometry
HUVEC and cells from induced and non-induced cul-
tures (after 7 days) were harvested using 0.05% trypsin-
EDTA and were washed twice in ice-cold PBS supple-
mented with 0.5% BSA and resuspended at 10
6 cells per
ml. Ten microliter of PE-conjugated mouse anti-human
CD146, CD73, CD29 and HLA-DR, FITC-conjugated
mouse anti-human CD34, CD90, CD45, CD13, CD184
and CD31, or APC-conjugated mouse anti-human
CD105, CD14 and CD44 antibodies (all from BD Bios-
ciences, except the anti-human CD105, which was pur-
chased from R&D systems) was added to 100 μl of cell
suspension (10
5 cells). Negative control staining was
performed using a FITC, PE, or APC-conjugated mouse
IgG1 isotype control antibodies, respectively. Cells were
incubated for 30 min at 4°C in dark, then were washed
with PBS to remove excess antibodies, and then were
resuspended in 500 μL of PBS and were analyzed using
BD FACS Calibour flow cytometer (BD Biosciences).
Living cells were gated in a dot plot of forward vs. side
scatter signals obtained on linear scale. At least, 5,000
gated events were acquired on a Log fluorescence scale.
Data were analyzed using Cell Quest Pro Software Ver-
sion 3.3 software (BD Biosciences).
Immunofluorescence staining
Adherent cells were fixed with 4% cold paraformalde-
hyde (Sigma) for 15 min and permeabilized with 0.1%
Triton X-100 (Sigma) for 10 min. After washing with
PBS, cells were blocked with 3% bovine serum albumin
(BSA, Sigma) for 30 min, followed by incubating with
primary antibodies against CD31 (5 μg/mL) VE-Cad-
herin (BV9; 1/25), eNOS (Endothelial Nitric Oxide
Synthase; 5 μl/mL), vWF (von Willebrand Factor; 4 F9;
10 μl / m L )a l la r ef r o mA b c a m( U S A )a n dV E G F( V E G F
165; 8 μg/mL; US Biological) at 4°C overnight. After
removal of primary antibodies, cells were washed three
times with PBS, and the FITC-labeled secondary anti-
body (goat polyclonal to mouse or rabbit IgG; both 1/
4000; Abcam) was added and incubated for 1 h at room
temperature. Cells were washed three times with PBS
and counter stained with DAPI (4’,6-diamidino-2-pheny-
lindole) nuclear dye and were observed under Leica
DM5000 B fluorescence microscope.
Osteogenic differentiation
Cells were seeded at a density of 0.05 × 10
6 cell/ml in 6
well plates (for cytochemical staining and RNA isola-
tion) and were grown for 24 h in standard DMEM
growth medium. At 70-80% confluence, the medium
was replaced in test wells by osteogenic induction med-
ium supplemented with DMEM containing 10% FBS, 1%
Pen Strep,50 μg/mL L-ascorbic acid (Wako Chemicals
GmbH, Neuss, Germany), 10 mM b-glycerophosphate
(Sigma), and 10 nM calcitriol [(1a,25-dihydroxy vitamin
D3) (sigma)], 10 nM Dexamethasone (Sigma). The
osteogenic medium was changed every 3 days and the
experiments were terminated at day 15. Cells cultured
in the regular culture medium were considered as
experiment control.
Adipocytic differentiation
Cells were seeded at a density of 0.05 × 10
6 cell/ml in 6
well plates (for cytochemical staining and RNA isola-
tion) and were grown for 24 h in standard DMEM
growth medium. At 90-100% confluence, the medium
was replaced in all test wells with adipogenic induction
medium supplemented with 10% FBS and adipogenic-
induction mixture (AIM) containing 10% Horse Serum
(Sigma), 1% Pen-strep, 100 nM dexamethasone, 0.45
mM isobutyl methyl xanthine [(IBMX) (Sigma)], 3 μg/
mL insulin (Sigma), and 1 μMR o s i g l i t a z o n e
[(BRL49653) (Novo Nordisk, Bagsvaerd, Denmark)]. The
adipogenic medium was replaced every 3 days, and
experiments were terminated at day 15. Cells cultured
in regular medium were considered as experiment
control.
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Cells were induced to osteoblasts differentiation for 15
days as described above, then cells were washed in PBS
twice, fixed in acetone/citrate buffer 10 mM (1.5: 1) at
pH 4.2 for 5 min at room temperature and incubated
with alkaline phosphatase (ALP) substrate solution
(naphthol AS-TR phosphate (Sigma) prepared 1:5 in
water plus 10 mg Fast red TR (Sigma), in 24 mL of 0.1
M Tris buffer, pH 9.0) for 1 h at room temperature.
Cells were rinsed with water, stored in PBS and photo-
graphed using Carl Zeiss–Axio observer.1 equipped with
a digital camera (Axiocam MRc5).
Oil red-O staining for adipocytes
Oil red-O stain was utilized to assess the accumulation
of cytoplasmic lipid droplets. Cells were differentiated
into adipocytes for 15 days, washed twice in PBS, fixed
in 4% formaldehyde for 10 min at room temperature,
rinsed once in 3% isopropanol, and stained for 1 h at
room temperature with filtered Oil red-O staining solu-
tion (prepared by dissolving 0.5 g Oil red-O powder in
60% isopropanol). Cells were rinsed with water then
photographed using Carl Zeiss–Axio observer.1
equipped with a digital camera (Axiocam MRc5).
Quantitative real-time PCR for gene expression
To measure the expression level of endothelial, adipo-
cyte and osteoblast-associated genes, total RNA was iso-
lated using the FastLane cDNA kit (Qiagen) according
to manufacturer’s instructions. Cell lysate containing
RNA from two independent treatments was combined
and quantitated. All samples were normalized to the
lowest concentration of RNA obtained. Complementary
DNA (cDNA) was synthesized from 4 μL of the normal-
ized RNA samples using FastLane cDNA kit according
to the manufacturer’s instructions. Relative levels of
mRNA were determined from cDNA by real time PCR
(Applied Biosystem-Real Time PCR Detection System)
with QuantiFast SYBR Green PCR kit (Qiagen) accord-
ing to the manufacturer’s instructions.
Endothelial-associated genes
The sequence for PCR primers (all from Invitrogen lim-
ited, UK) were as follows (5’-3’): VEGFR2 (KDR/flk1; Fw:
CTTACCCCAGGATATGGAG and Rev: CCGTCAAGG-
GAAAGACTACG), VE-Cadherin (CD144; Fw: CCCGTC
TTTACTCAATCCACA and Rev: GGGTTTGATGA
TACCCTCGTT), FVIII (AHF; Fw: GTTCGTCCTGG
AAGGATCGG and Rev: CACTGACACCTGAGTGA-
GAC) and VCAM-1 (CD106; Fw: TCTCATTGACTTG-
CAGCACC and Rev: TTCTTGCAGCTTTGTGGATG),
b-actin (Fw: AGCCATGTACGTTGCTA and Rev:
AGTCCGCCTAGAAGCA).
Adipocyte and osteoblast-associated genes
The sequence for PCR primers (all from Invitrogen lim-
ited, UK) were as follows (5’-3’): PPAR-g 2( F w :
CTCCACTTTGATTGCACTTTGG and Rev: TTCT
CCTAT TGACCCAGAAAGC), aP2 (Fw: TGGTTGAT
TTTCCATCCCAT and Rev: GCCAGGAATTTGACG
AAGTC), Adiponectin (Fw: ATGTCTCCCTTAGGAC
CAATAAG and Rev: TGTTGCTGGGAGCTGTTC
TACTG), ALP (Fw: ACGTGGCTAAGAATGTCATC
and Rev: CTGGTAGGCGATGTCCTTA), Osteocalcin
(Fw: AGAGCGACACCCTAGAC and Rev: CATGA-
GAGCCCTCACA) and Osteopontin (Fw: GGTGA
TGTCCTCGTCTGTA and Rev: CCAAGTAAGTC
CAACGAAAG). The relative abundance of target
mRNA was quantified relative to the control b-actin
gene expression from the same reaction setup, using the
2
-ΔΔCT method [62].
Additional material
Additional file 1: Figure S1. Flow cytometry analysis of stromal
associated markers on induced cells. All the groups expressed CD13,
CD29, CD44, CD73, CD90, and CD105. Filled histograms represent cells
stained by the corresponding isotype control antibody. Five thousand
events were acquired for analysis.
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